A new analysis of diabetes medications Avandia (rosiglitazone) and Actos (pioglitazone) revealed that the risk of heart attack and/or heart failure, or death were the same, approximately 4%. The study has been published in the latest issue of Circulation: Cardiovascular Quality and Outcomes , an American Heart Association journal.
Takeda Pharmacuetical Co. makes Actos, while GlaxoSmithKline (GSK) makes Avandia. (more…)
Individuals who take insulin for diabetes are at a greater risk of developing cancer‚ Danish researchers say‚ although they cannot yet explain this association.
The study, to be presented next month in Stockholm at the European Association for the Study of Diabetes’ annual conference‚ found that patients on insulin are 50 percent more likely to develop cancer compared with the general population. The researchers, taking data from (more…)
Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of Medicine. As a result, the human race may have been evolving in the recent past to be more susceptible, rather than less, to some complex diseases, they conclude.
“At first we were completely shocked because, without (more…)
Gene variants that are currently associated with an increased risk of type 1 diabetes may have given previously unknown benefits to their human carriers‚ say researchers at the Stanford University School of Medicine.
These gene variants may have caused the human race in the recent past to evolve and become more susceptible to some complex diseases, such as diabetes. Atul Butte‚ MD, PhD‚ assistant professor of pediatric cancer biology (more…)